Should We Continue Assessing Glomerular Filtration Rate with the Cockroft–Gault Formula in NOAC-Treated Patients? The Magnitude of the Problem
Despite the proven superiority of the Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) over the Cockcroft–Gault (CG) formula, current guidelines recommend the latter to assess renal function in patients treated with non-vitamin K antagonist oral anticoagulants (NOACs). To assess the relat...
Main Authors: | Roberto Cemin, Luisa Foco, Carmine Zoccali, Raffaele De Caterina |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-06-01
|
Series: | Journal of Clinical Medicine |
Subjects: | |
Online Access: | https://www.mdpi.com/2077-0383/9/6/1893 |
Similar Items
-
Safety of once- or twice-daily dosing of non-vitamin K antagonist oral anticoagulants (NOACs) in patients with nonvalvular atrial fibrillation: A NOAC-TR study
by: Sadık Volkan Emren, et al.
Published: (2018-05-01) -
Assessing adherence and persistence to non-vitamin K antagonist oral anticoagulants (NOACs) among patients with atrial fibrillation in tertiary-care referral centers in Malaysia
by: Mohammed A Kubas, et al.
Published: (2020-01-01) -
Clopidogrel or ticagrelor alongside dabigatran in acute coronary syndrome and indication for NOAC: A study rationale
by: Luijkx, J., et al.
Published: (2022) -
Non-vitamin K antagonist oral anticoagulants (NOACs) in cancer patients with atrial fibrillation
by: Anetta Undas, et al.
Published: (2019-12-01) -
Comparison of the Cockroft–Gault, simplified Modification of Diet in Renal Disease, and Chronic Kidney Disease Epidemiology Collaboration formulas in the determination
of chronic kidney disease advancement
by: Jolanta Szeliga-Król, et al.
Published: (2016-09-01)